Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
AstraZeneca: A Triple Shot Of Income, Growth, And Value
07:30am, Saturday, 27'th Apr 2024
Since I covered AstraZeneca last October, shares have narrowly outperformed the S&P 500 index. Thanks to impressive results throughout the business, the company's total revenue and core EPS jumped in
BHP, Anglo American, Meta, Google, Microsoft, AstraZeneca, Rubrik, ComCast and more - Markets Defused
06:03am, Saturday, 27'th Apr 2024
Markets Defused aims to present an easy-to-understand and straightforward recap of the week's most engaging stock market news BHP takeover approach spurned by Anglo American Meta shareholders have an
AstraZeneca shares worth £135, says investment bank
05:55am, Friday, 26'th Apr 2024
Barclays has raised its price target for shares in AstraZeneca PLC (LSE:AZN) after Thursday's significantly better-than-expected first-quarter numbers. The investment banking arm of the high street le
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
02:50pm, Thursday, 25'th Apr 2024
AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease drugs.
AstraZeneca Shares Jump Most Since 2020
01:58pm, Thursday, 25'th Apr 2024
Pascal Soriot, CEO of AstraZeneca, joins the Bloomberg Intelligence to discuss AstraZeneca earnings, along with regulatory and scientific updates. He spoke with Paul Sweeney and Molly Smith on Bloombe
AstraZeneca CEO talks blowout earnings, global growth, new drugs, and pricing
01:49pm, Thursday, 25'th Apr 2024
AstraZeneca shares (AZN) revealed a first-quarter earnings beat on Thursday, posting revenue of $12.68 billion, a 19% year-over-year gain. In addition, the pharmaceutical giant has reiterated its full
AstraZeneca Gets a Boost From Sales of Its Cancer Drugs
12:40pm, Thursday, 25'th Apr 2024
American depositary receipts (ADRs) of AstraZeneca (AZN) traded near their all-time high as the Anglo-Swedish pharmaceutical company had solid first-quarter demand for its cancer drugs.
Is "Bad News" Still "Good News" for the Market?
11:35am, Thursday, 25'th Apr 2024
Thursday, April 25th, 2024 Pre-market futures are plummeting at this hour. We began the early trading session down anyway, based on earnings disappointments from Meta META and IBM IBM after yesterday'
AstraZeneca tops first-quarter revenue and profit expectations
11:30am, Thursday, 25'th Apr 2024
AstraZeneca CEO Pascal Soriot outlines how the pharma giant's first-quarter results were boosted by demand for its rare blood disorder and oncology drugs.
AstraZeneca is now Britain's top stock- can it move higher?
08:10am, Thursday, 25'th Apr 2024
AstraZeneca PLC (LSE:AZN)'s first-quarter results were thoroughly welcomed by the market. So much so, that its market valuation has surpassed oil major Shell to become Britain's most valuation corpora
AstraZeneca earnings beat expectations as steady drug sales boost revenues
07:41am, Thursday, 25'th Apr 2024
AstraZeneca plc today, on April 25, announced its earnings report for the first quarter of FY24. Total Revenue increased by 19% to $ 12,679 million, driven by an 18% increase in product sales and cont
AstraZeneca overtakes Shell as Britain's most valuable company.
06:41am, Thursday, 25'th Apr 2024
AstraZeneca PLC (LSE:AZN)'s solid rally following Thursday's first-quarter earnings print has made the pharmaceuticals giant Britain's most valuable company, overtaking oil major Shell. AstraZeneca po
AstraZeneca CFO on Earnings, US Inflation Reduction Act, China Market
03:25am, Thursday, 25'th Apr 2024
AstraZeneca Chief Financial Officer Aradhana Sarin discusses first-quarter earnings, implications of the US Inflation Reduction Act and the outlook for the company's commercial business in China. She
AstraZeneca ticks the boxes in first quarter
03:03am, Thursday, 25'th Apr 2024
Britain's leading pharmaceuticals company AstraZeneca hit the mark in today's first-quarter earnings print. Total revenue increased by 19% at constant exchange rates to $12.7 billion (£10.2 billion),
AstraZeneca beats first-quarter revenue, profit estimates
02:06am, Thursday, 25'th Apr 2024
AstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by resilient demand for its oncology and rare blood disorder drugs.
